Reuse of "highly permeable" dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent.

ASAIO transactions Pub Date : 1991-10-01
B Canaud, Q V Nguyen, L J Garred, R Nicolle, C Mion
{"title":"Reuse of \"highly permeable\" dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent.","authors":"B Canaud,&nbsp;Q V Nguyen,&nbsp;L J Garred,&nbsp;R Nicolle,&nbsp;C Mion","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the past few years, dialyzer reuse has gained increased clinical acceptance. This has been due both to the availability of automated reconditioning machines and powerful chemical cleaning and disinfecting agents. In this study the authors evaluated the effectiveness of a newly available peroxyacetic acid solution (PAS) (Dialox) as the dual cleaning and disinfecting agent in the reuse of highly permeable dialyzers. An in vivo study was conducted with ten patients already involved in our center's reuse program using the Renatron reprocessing machine and PAS at various dilutions. One hundred forty dialyzers of three different brands and membrane types (HF80 used for hemodiafiltration [HDF], Filtral 16 used for hemodialysis [HD], and FH88 used for hemofiltration [HF]) were employed for a total of 1182 treatments, giving an average 8.4 uses per module. Significantly more uses were obtained with the HF80 and Filtral 16 dialyzers (9.7 and 9.4, respectively) than for the FH88 modules used by the HF patients (6.7 uses per module). Compromised cleaning by backfiltration due to the lack of a second dialysate port on the FH88 may be a possible explanation. Greater membrane plugging due to higher ultrafiltration rates in HF may be another factor. Patient variability was found to be another factor in dialyzer reuse. The cleaning effectiveness of various dilutions of PAS was also tested in this study. The number of uses achieved was not found to vary significantly with PAS strength; however, a greater frequency of second or third reprocessing was required with more dilute cleaning solution. The authors found the dilution achieved on the Renatron reprocessing machine using the currently marketed PAS concentrate to be the most cost effective.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 4","pages":"653-7"},"PeriodicalIF":0.0000,"publicationDate":"1991-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASAIO transactions","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the past few years, dialyzer reuse has gained increased clinical acceptance. This has been due both to the availability of automated reconditioning machines and powerful chemical cleaning and disinfecting agents. In this study the authors evaluated the effectiveness of a newly available peroxyacetic acid solution (PAS) (Dialox) as the dual cleaning and disinfecting agent in the reuse of highly permeable dialyzers. An in vivo study was conducted with ten patients already involved in our center's reuse program using the Renatron reprocessing machine and PAS at various dilutions. One hundred forty dialyzers of three different brands and membrane types (HF80 used for hemodiafiltration [HDF], Filtral 16 used for hemodialysis [HD], and FH88 used for hemofiltration [HF]) were employed for a total of 1182 treatments, giving an average 8.4 uses per module. Significantly more uses were obtained with the HF80 and Filtral 16 dialyzers (9.7 and 9.4, respectively) than for the FH88 modules used by the HF patients (6.7 uses per module). Compromised cleaning by backfiltration due to the lack of a second dialysate port on the FH88 may be a possible explanation. Greater membrane plugging due to higher ultrafiltration rates in HF may be another factor. Patient variability was found to be another factor in dialyzer reuse. The cleaning effectiveness of various dilutions of PAS was also tested in this study. The number of uses achieved was not found to vary significantly with PAS strength; however, a greater frequency of second or third reprocessing was required with more dilute cleaning solution. The authors found the dilution achieved on the Renatron reprocessing machine using the currently marketed PAS concentrate to be the most cost effective.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以过氧乙酸作为唯一清洁和消毒剂的“高渗透性”透析器的重复使用。
在过去的几年中,透析器的重复使用获得了越来越多的临床认可。这是由于自动修复机器和强大的化学清洁和消毒剂的可用性。在这项研究中,作者评估了一种新出现的过氧乙酸溶液(PAS) (dialx)作为双重清洁和消毒剂在高渗透性透析器重复使用中的有效性。我们使用Renatron再处理机器和不同稀释度的PAS对10名已经参与我们中心再利用计划的患者进行了体内研究。三种不同品牌和膜型的140台透析器(HF80用于血液透析[HDF], Filtral 16用于血液透析[HD], FH88用于血液过滤[HF])共用于1182次治疗,平均每个模块8.4次使用。HF80和Filtral 16透析器的使用次数(分别为9.7次和9.4次)明显高于HF患者使用的FH88模块(每个模块6.7次)。由于FH88上缺乏第二个透析端口,反过滤导致的清洗受损可能是一个可能的解释。在HF中,由于超滤速率较高而导致的更大的膜堵塞可能是另一个因素。患者的差异被发现是透析器重复使用的另一个因素。本研究还测试了不同稀释度的PAS的清洁效果。实现的使用数量没有发现PAS强度的显著差异;但是,需要用更稀的清洗溶液进行更频繁的第二次或第三次再处理。作者发现,使用目前市场上销售的PAS浓缩液在Renatron再处理机上实现的稀释是最具成本效益的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mechanism of dialysis-induced hypotension. Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. Influence of centrifugal blood pumps on the elasticity of erythrocytes. Reuse of "highly permeable" dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1